persistentone
Established Member
- Reaction score
- 27
Is the Phase III study for Follica still recruiting any patients, and which medical centers are performing the research in the US?
@That Guy How do you know that...? Maybe yes...
Follica is a private company. This company is not obliged to provide information in any case. They could be starting phase 3 perfectly.There is no announcement from PureTech and you can check the federal/privately funded clinical trials registries for yourself.
Follica is a private company. This company is not obliged to provide information in any case. They could be starting phase 3 perfectly.
They are started phase 3. You can believe it.They have not kept information about their trial status secret, though. Go on Puretech's website and you'll find a chart that shows where in the timeline their products fall. Follica's has filled the pre-clinical, phase 1, and phase 2 bars, but the phase 3 is still blanked out.
So unless they've simply not got around to it, which I doubt, there is no reason to believe they've started.
Yeah sure, broFollica is close to release.
So sorry man.Yeah sure, bro
Lol sry, but how could you possibly know that?Follica is close to release.
There is no announcement from PureTech and you can check the federal/privately funded clinical trials registries for yourself.
Let's stick to evidence-based claims. If you want to fling your opinions at someone's face, they're eventually going to fling right back and it will be a shitshow.So sorry man.
They are started phase 3. You can believe it.
Found this in regards to the pure tech health report sharesmagazine.co.uk (I am new so it won't let me post the link, it is on that site however)
" Additional progress has also been made toward the initiation of the Follica RAIN pivotal study in androgenetic alopecia as well as the identification and testing of next-generation, proprietary compounds based on the Group's intellectual property. The Follica RAIN pivotal study is expected to commence in the first half of 2018, following the completion of an optimisation study that is expected to begin imminently. The Follica RAIN platform builds on new insights into cell signalling and leverages immune pathways activated during wound healing to create new hair follicles and hair in adult skin."
